You're on Stage2Stocks US, for NYSE and Nasdaq stocks.Go to Indian stocksYou picked Stage2Stocks India last time.Go to Indian stocks

Markets

Sectors

Screener

Learn

Ask AI
Sign up / Login

Nordicus Partners Corporation is left out of our screens and market counts tonight, which cover US stocks priced at $5 or more and trading at least $1 million a day on average. Its read below still updates after every close.

Nordicus Partners Corporation

Stage 2 · Advancing · week 3

As of Nov 3, 2026, Nordicus Partners is in Stage 2, the uptrend phase, now in week 3 (since Oct 20, 2026). It closed at $4.10, 19.4% below its 52-week high and above its 200-day average, which is falling. In Industrials, 20.3% of stocks are in Stage 2.

Every stock that changed stage on Oct 20, 2026 →

Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. More about the company

$4.10
Close, Nov 3, 2026
+11.42% on the day
$79.7M · Micro cap
Market Neutral — FadingIndustrials 20.3% in Stage 2-6.8 pts / 20dConsulting Services 45.5%+1.0 pts

Pro read

Pro

Our read

A young uptrend, not yet established

Setup score

—

Momentum

Steady

Is NORD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $29 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2026-10-19 → 2026-11-03
S2 2w
2026-10-192026-11-03
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 1w → S2 2w current
Total tracked: 2 weeks across 2 stage runs.

NORD among Consulting Services

All 11 →
Stocks in Consulting Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1SBCStage 2 · wk 689−2.4%
2FORRStage 2 · wk 1778−14.8%
3ICFIStage 2 · wk 1270+17.8%
4HURNStage 2 · wk 869+23.8%
5FCNStage 4 · wk 1066+40.3%
6CRAIStage 2 · wk 256+14.0%
7BAHStage 1 · wk 955+26.8%
8VRSKStage 4 · wk 646+20.7%
vs 52W High
-19.4%
$1.63 lo$5.09 hi
19.4% below 52W high, deeper pullback
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 3
1w13w26w
Week 3, fresh breakout
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
15.0%
200 DMA: $3.57 · sloping down
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
4.75x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
Short-term trend rising strongly
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+2.0%
3M
+82.2%
6M
+2.5%
YTD
-18.0%
1Y
-18.0%
Sector
Industrials
↓ Peaking
Stage 2%
20.3%
20d Δ
-6.8pp
1M return
+2.2%
3M return
-5.1%
Sector Stage-2 % · last 20 days
This stock ranks #89 of 89 Stage 2 stocks in Industrials by RS. Lagging sector peers.
Industry
Consulting Services
↑ Building
Stage 2%
45.5%
20d Δ
+1.0pp
1M return
+62.3%
3M return
+17.8%
Industry Stage-2 % · last 20 days
Ranks #6 of 5 Stage 2 stocks in this industry.
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-11-03S2
Wk 3 · Vol 4.75x
2026-11-02S2
Wk 2 · Vol 5.85x
2026-10-30S2
Wk 2 · Vol 20.75x
2026-10-29S2
Wk 2 · Vol 10.89x
2026-10-28S2
Wk 2 · Vol 0.00x
2026-10-27S2
Wk 2 · Vol 0.31x
2026-10-26S2
Wk 1 · Vol 2.38x
2026-10-23S2
Wk 1 · Vol 2.26x
2026-10-22S2
Wk 1 · Vol 0.03x
2026-10-21S2
Wk 1 · Vol 0.00x
2026-10-20S21→2
Wk 1 · Vol 0.14x
2026-10-19S1
Wk 1 · Vol 0.92x
Moving averages & range
50 DMA
$3.87
200 DMA
$3.57
52W High
$5.09
52W Low
$1.63
5D Low
$3.68
Resistance levels (recent highs)
20d High
$5.09
60d High
$5.09
120d High
$5.09
250d High
$5.09
Next resistance
+24.1%
to 20d High
ROE
-8.2%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 1.3

Against its industry

Consulting Services · 25 companies we cover

  • Return on equity-8.2%

    Higher return on equity than 52%

  • Profit margin0.0%

    Wider margin than 42%

  • Debt to equity0.00x

    Less debt than 100%

  • Dividend yield0.00%

    Higher yield than 0%

Nordicus Partners: quick answers

What stage is Nordicus Partners in?

As of Nov 3, 2026, Nordicus Partners (NORD) is in Stage 2, the uptrend phase. It entered Stage 2 on Oct 20, 2026 and is in week 3. What the four stages mean

Is Nordicus Partners in an uptrend?

Yes. Nordicus Partners is in a Stage 2 uptrend. It trades 15.0% above its 200-day average, which is falling.

How far is Nordicus Partners from its 52-week high?

Nordicus Partners closed at $4.10 on Nov 3, 2026, 19.4% below its 52-week high of $5.09. Its 52-week low is $1.63.

How has Nordicus Partners performed over the past year?

As of Nov 3, 2026, Nordicus Partners is down 18.0% over the past year and down 18.0% so far in 2026.

Which sector and industry is Nordicus Partners in?

Nordicus Partners is in the Consulting Services industry, part of the Industrials sector. 89 stocks in Industrials are in Stage 2, 20.3% of the sector. See the Stage 2 stocks in Consulting Services

About this companyIndustrials· Consulting Services

Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-03. Past data patterns are not indicative of future results. This page is a data analytics tool only.